200 related articles for article (PubMed ID: 31559586)
1. Identification of inflammatory mediators associated with metastasis of oral squamous cell carcinoma in experimental and clinical studies: systematic review.
Elhousiny M; Miller K; Ariyawadana A; Nimmo A
Clin Exp Metastasis; 2019 Dec; 36(6):481-492. PubMed ID: 31559586
[TBL] [Abstract][Full Text] [Related]
2. Prognostic biomarkers in oral squamous cell carcinoma: A systematic review.
Rivera C; Oliveira AK; Costa RAP; De Rossi T; Paes Leme AF
Oral Oncol; 2017 Sep; 72():38-47. PubMed ID: 28797460
[TBL] [Abstract][Full Text] [Related]
3. Mediators of Inflammation - A Potential Source of Biomarkers in Oral Squamous Cell Carcinoma.
Tampa M; Mitran MI; Mitran CI; Sarbu MI; Matei C; Nicolae I; Caruntu A; Tocut SM; Popa MI; Caruntu C; Georgescu SR
J Immunol Res; 2018; 2018():1061780. PubMed ID: 30539028
[TBL] [Abstract][Full Text] [Related]
4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
5. Tumour budding in oral squamous cell carcinoma: a meta-analysis.
Almangush A; Pirinen M; Heikkinen I; Mäkitie AA; Salo T; Leivo I
Br J Cancer; 2018 Feb; 118(4):577-586. PubMed ID: 29190636
[TBL] [Abstract][Full Text] [Related]
6. Could salivary biomarkers be useful in the early detection of oral cancer and oral potentially malignant disorders, and is there a relationship between these biomarkers and risk factors?
Elmahgoub F
Evid Based Dent; 2022 Mar; 23(1):30-31. PubMed ID: 35338326
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of CircRNAs expression in oral squamous cell carcinoma.
Zhang L; Wang M; Ren W; Li S; Zhi K; Gao L; Zheng J
Oral Dis; 2023 May; 29(4):1439-1453. PubMed ID: 35286741
[TBL] [Abstract][Full Text] [Related]
8. Involvement of an autocrine stromal cell derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma.
Uchida D; Onoue T; Tomizuka Y; Begum NM; Miwa Y; Yoshida H; Sato M
Mol Cancer Res; 2007 Jul; 5(7):685-94. PubMed ID: 17634424
[TBL] [Abstract][Full Text] [Related]
9. NDRG1 deficiency is associated with regional metastasis in oral cancer by inducing epithelial-mesenchymal transition.
de Lima JM; Morand GB; Macedo CCS; Diesel L; Hier MP; Mlynarek A; Kowalski LP; Maschietto M; Alaoui-Jamali MA; da Silva SD
Carcinogenesis; 2020 Jul; 41(6):769-777. PubMed ID: 32112078
[TBL] [Abstract][Full Text] [Related]
10. Clinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis.
Zhou J; Huang S; Wang L; Yuan X; Dong Q; Zhang D; Wang X
World J Surg Oncol; 2017 May; 15(1):104. PubMed ID: 28521842
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological parameters, recurrence, locoregional and distant metastasis in 115 T1-T2 oral squamous cell carcinoma patients.
Jerjes W; Upile T; Petrie A; Riskalla A; Hamdoon Z; Vourvachis M; Karavidas K; Jay A; Sandison A; Thomas GJ; Kalavrezos N; Hopper C
Head Neck Oncol; 2010 Apr; 2():9. PubMed ID: 20406474
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic significance of survivin expression in patients with oral squamous cell carcinoma: evidence from a meta-analysis.
Xie S; Xu H; Shan X; Liu B; Wang K; Cai Z
PLoS One; 2015; 10(2):e0116517. PubMed ID: 25710884
[TBL] [Abstract][Full Text] [Related]
13. The budding and depth of invasion model in oral cancer: A systematic review and meta-analysis.
Wahab A; Onkamo O; Pirinen M; Almangush A; Salo T
Oral Dis; 2022 Mar; 28(2):275-283. PubMed ID: 33031610
[TBL] [Abstract][Full Text] [Related]
14. Gα₁₂ drives invasion of oral squamous cell carcinoma through up-regulation of proinflammatory cytokines.
Jian SL; Hsieh HY; Liao CT; Yen TC; Nien SW; Cheng AJ; Juang JL
PLoS One; 2013; 8(6):e66133. PubMed ID: 23762476
[TBL] [Abstract][Full Text] [Related]
15. Predictive Prognostic Value of Tissue-Based MicroRNA Expression in Oral Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
Troiano G; Mastrangelo F; Caponio VCA; Laino L; Cirillo N; Lo Muzio L
J Dent Res; 2018 Jul; 97(7):759-766. PubMed ID: 29533734
[TBL] [Abstract][Full Text] [Related]
16. Role of selected salivary inflammatory cytokines in the diagnosis and prognosis of oral squamous cell carcinoma. A Systematic Review and Meta-analysis.
Benito-Ramal E; Egido-Moreno S; González-Navarro B; Jané-Salas E; Roselló-Llabrés X; López-López J
Med Oral Patol Oral Cir Bucal; 2023 Sep; 28(5):e474-e486. PubMed ID: 37099710
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory mediators drive metastasis and drug resistance in head and neck squamous cell carcinoma.
St John MA
Laryngoscope; 2015 Mar; 125 Suppl 3():S1-11. PubMed ID: 25646683
[TBL] [Abstract][Full Text] [Related]
18. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
Bose P; Klimowicz AC; Kornaga E; Petrillo SK; Matthews TW; Chandarana S; Magliocco AM; Brockton NT; Dort JC
BMC Cancer; 2012 Aug; 12():332. PubMed ID: 22852863
[TBL] [Abstract][Full Text] [Related]
19. Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma.
Uehara M; Sano K; Ikeda H; Sekine J; Irie A; Yokota T; Tobita T; Ohba S; Inokuchi T
Oral Oncol; 2004 Mar; 40(3):321-5. PubMed ID: 14747064
[TBL] [Abstract][Full Text] [Related]
20. Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma.
Sun Y; Wang S; Zhang X; Wu Z; Li Z; Ding Z; Huang X; Chen S; Jing Y; Zhang X; Ding L; Song Y; Sun G; Ni Y
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
